Clinical Study
Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience
Table 2
HCC versus non-HCC patients: clinical, pathological, and follow-up characteristics.
| | HCC | Non-HCC | value |
| Patients | 63 | 67 | | Age (±SDa) (range) years | (18–85) | (21–88) | <0.01 | Male/female | 18/45 | 21/46 | NS* | Tumour size (±SDa) (range) mm | (6–100) | (5–65) | <0.05 | Distant metastasis at diagnosis | 1 | 3 | NS* | pT stage | | | | T1/T2/T3 | 14/30/19 | 22/33/12 | NS* | pN stage | | | | NX/N0/N1 | 62/0/1 | 67/0/0 | NS* | pM stage | | | | M0/M1 | 62/1 | 64/3 | NS* | MI/WI | 25/38 | 41/26 | <0.05 | Multifocal disease | 3 | 1 | NS* | Microcarcinoma | 4 | 3 | NS* | Concomitant PTC | 8 | 13 | NS* | Follow-up yes/no | 58/5 | 59/8 | NS* | Follow-up (±SDa) (range) months | (17–179) | (29–174) | NS* | RAI/no RAI | 55/3 | 50/9 | NS* | Distant metastasis at follow-up | 3 | 0 | NS* |
|
|
SDa: standard deviation; NS*: not significant.
|